Pfizer,
BioNTech Seek To Nix Moderna Vax IP Suit, Countersue
By Dave Simpson
Several
Moderna patents related to technology behind the mRNA platform in COVID-19
vaccines are invalid, rival vaccine-makers Pfizer Inc. and BioNTech told a
Massachusetts federal judge on Monday in a bid to dismiss Moderna's
infringement suit and in counterclaims of their own.
2
documents attached | Read full article »
No comments:
Post a Comment